Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02864992
Brief Title: Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations (VISION)

First Submitted : July 29, 2016
First Submitted that Met QC Criteria : August 9, 2016
First Posted : August 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 26, 2019
Last Update Posted : June 28, 2019